The Lancet Infectious Diseases 今日热榜-jinrirebang.top



The Lancet Infectious Diseases The Lancet Infectious Diseases

1.	[Articles] Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial	Muge Cevik, Lindsay C Thompson, Caryn Upton, Valéria Cavalcanti Rolla, Mookho Malahleha, Blandina Mmbaga, Nosipho Ngubane, Zamzurina Abu Bakar, Mohammed Rassool, Ebrahim Variava, Rodney Dawson, Suzanne Staples, Umesh Lalloo, Cheryl Louw, Francesca Conradie, Marika Eristavi, Anastasia Samoilova, Sergey N Skornyakov, Niyanda Elias Ntinginya, Frederick Haraka, George Praygod, Harriett Mayanja-Kizza, Janice Caoili, Vincent Balanag, Margareth Pretti Dalcolmo, Timothy McHugh, Robert Hunt, Priya Solanki, Anna Bateson, Angela M Crook, Stella Fabiane, Juliano Timm, Eugene Sun, Melvin Spigelman, Derek J Sloan, Stephen H Gillespie, SimpliciTB Consortium	
2.	[Comment] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis	Guofang Deng, Liang Fu	
3.	[Articles] Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study	Ida Rask Moustsen-Helms, Peter Bager, Tine Graakjær Larsen, Frederik Trier Møller, Lasse Skafte Vestergaard, Morten Rasmussen, Christian Holm Hansen, SSI-DMC Study Group	
4.	[Comment] Immune evasiveness of SARS-CoV-2 variants and vaccine selection	Malin Inghammar, Fredrik Kahn	
5.	[Articles] Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study	Jelte Elsinga, Temmy Sunyoto, Letizia di Stefano, Pier Francesco Giorgetti, Htet Aung Kyi, Chiara Burzio, Ximena Campos Moreno, Chiedozie K Ojide, Nnennaya Ajayi, Richard Ewah, Emeka O Ogah, Chioma Dan-Nwafor, Anthony Ahumibe, Chinwe Lucia Ochu, Adebola Olayinka, Sylvie Jonckheere, Pascale Chaillet, Michel van Herp	
6.	[Comment] Rapid diagnostic tests for Lassa fever: what do we aim for?	Mirjam Groger, Michael Ramharter	
7.	[Personal View] Urgent considerations for booster vaccination strategies against Ebola virus disease	Wim Adriaensen, Selien Oostvogels, Yves Levy, Bailah Leigh, Hugo Kavunga-Membo, Deborah Watson-Jones	
8.	[Personal View] Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity	Mathew Mercuri, Kristy Hackett, Ruanne V Barnabas, Claudia I Emerson	
9.	[Comment] Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities	Dvora Joseph Davey, Alex de Voux, Lerato Hlatshwayo, Aurelie Nelson, Lisa Frigati, Kalisha Bheemraj, Nafisa Wara, Rufaro Mvududu, Landon Myer	
10.	[Comment] Asymptomatic parasitemia and RTS,S vaccine efficacy	Nobuko Arisue, Nirianne Marie Q Palacpac	
11.	[Correspondence] Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam	Paul C Adamson, Vu N Hieu, Pham H Nhung, DM Whiley, TM Chau	
12.	[Corrections] Correction to Lancet Infect Dis 2024; published online April 3. https://doi.org/10.1016/S1473-3099(24)00142-7		
13.	[Articles] Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial	Michal Juraska, Angela M Early, Li Li, Stephen F Schaffner, Marc Lievens, Akanksha Khorgade, Brian Simpkins, Nima S Hejazi, David Benkeser, Qi Wang, Laina D Mercer, Samuel Adjei, Tsiri Agbenyega, Scott Anderson, Daniel Ansong, Dennis K Bii, Patrick B Y Buabeng, Sean English, Nicholas Fitzgerald, Jonna Grimsby, Simon K Kariuki, Kephas Otieno, François Roman, Aaron M Samuels, Nelli Westercamp, Christian F Ockenhouse, Opokua Ofori-Anyinam, Cynthia K Lee, Bronwyn L MacInnis, Dyann F Wirth, Peter B Gilbert, Daniel E Neafsey	
14.	[Comment] Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection	Vicente Soriano, Víctor Moreno-Torres	
15.	[Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study	Huwen Wang, Yuchen Wei, Chi Tim Hung, Guozhang Lin, Xiaoting Jiang, Conglu Li, Katherine Min Jia, Carrie Ho Kwan Yam, Tsz Yu Chow, Janice Ying-en Ho, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Eng Kiong Yeoh, Ka Chun Chong	
16.	[Correspondence] Shifting transmission patterns of human mpox in South Kivu, DR Congo	Patrick DMC Katoto, Winters Muttamba, Esto Bahizire, Espoir Bwenge Malembaka, Henry Kyobe Bosa, Dieudonné Mwamba Kazadi, Gaston Lubambo, Freddy Belesi Siangoli, Barnabas Bakamutumaho, Misaki Wayengera, Don Jethro Mavungu Landu, Daniel Mukadi-Bamuleka, Placide Mbala, Mark Loeb, Bruce Kirenga, Jean-Jacques Muyembe-Tamfum	
17.	[Articles] Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study	Sonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, Jacobo Pardo-Seco, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Suárez-Gaiche, Rolf Kramer, Jing Jin, Leticia Platero-Alonso, Rosa-María Alvárez-Gil, Olga-María Ces-Ozores, Victoria Nartallo-Penas, Susana Mirás-Carballal, Marta Piñeiro-Sotelo, Alberto Malvar-Pintos, Juan-Manuel González-Pérez, Carmen Rodríguez-Tenreiro-Sánchez, Irene Rivero-Calle, Antonio Salas, Carmen Durán-Parrondo, Federico Martinón-Torres, NIRSE-GAL study group	
18.	[Correspondence] Reporting of deaths during cholera outbreaks: case fatality ratio and community deaths	Flavio Finger, Kristen Heitzinger, David Berendes, Iza Ciglenecki, Morgane Dominguez, Kate Alberti, Emmanuel Baron, Philippe Barboza	
19.	[Comment] Early life respiratory syncytial virus disease—a preventable burden	Cheryl Cohen, Heather J Zar	
20.	[Corrections] Correction to Lancet Infect Dis 2019; 19: 1380		
21.	[Articles] Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study	Morgan K Walker, Guoqing Diao, Sarah Warner, Ahmed Babiker, Maniraj Neupane, Jeffrey R Strich, Christina Yek, Sameer S Kadri, National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI)	
22.	[Articles] Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial	Kirsten E Lyke, Joel V Chua, Michael Koren, Heather Friberg, Gregory D Gromowski, Rekha R Rapaka, Adam T Waickman, Sudhaunshu Joshi, Kathleen Strauss, Michael K McCracken, Hernando Gutierrez-Barbosa, Biraj Shrestha, Christopher Culbertson, Paula Bernal, Rafael A De La Barrera, Jeffrey R Currier, Richard G Jarman, Robert Edelman	
23.	[Comment] Lessons for dengue vaccines from a human challenge study	Eng Eong Ooi, Shirin Kalimuddin	
24.	[Comment] Carbapenem use in US hospitals: guidance and stewardship	Erika J Ernst	
25.	[Articles] Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)	Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mayfong Mayxay, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Elizabeth A Ashley, Arjen M Dondorp, Nicholas P J Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White, James A Watson, PLATCOV Collaborative Group	
26.	[Comment] Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape	Leo G Visser	
27.	[Comment] Reducing risks from respiratory pathogens at the 2024 Hajj	Ziad A Memish, Majid M Alshamrani, Rana F Kattan, Esam I Azhar, Fayssal M Farahat, Ali M Albarrak, Alimuddin Zumla	
28.	[Media Watch] Community perspectives on abortion in eastern South Africa	Sylvia Warren	
29.	[Articles] The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China	Wenting Zuo, Di He, Chaoyang Liang, Shiyu Du, Zhan Hua, Qiangqiang Nie, Xiaofeng Zhou, Meng Yang, Haidong Tan, Jiuyang Xu, Yanbing Yu, Yuliang Zhan, Ying Zhang, Xiaoying Gu, Weijie Zhu, Hui Zhang, Hongyan Li, Weiliang Sun, Mingzhi Sun, Xiaolei Liu, Liguo Liu, Chuanzhen Cao, Rui Li, Jing Li, Yun Zhang, Yuting Zhang, Jing Guo, Ling Zhao, Chuan-Peng Zhang, Hongyu Liu, Shiyao Wang, Fei Xiao, Yeming Wang, Zai Wang, Haibo Li, Bin Cao	
30.	[Comment] Long COVID and SARS-CoV-2 persistence: new answers, more questions	Danilo Buonsenso, Kelan G Tantisira	
31.	[Newsdesk] Pertussis outbreak in Czech Republic	Ed Holt	
32.	[Media Watch] Family and sexual behaviour in South Africa	Hollie Sherwood-Martin	
33.	[Historical Review] Social histories of public health misinformation and infodemics: case studies of four pandemics	Sabrina L Jin, Jessica Kolis, Jessica Parker, Dylan A Proctor, Dimitri Prybylski, Claire Wardle, Neetu Abad, Kathryn A Brookmeyer, Christopher Voegeli, Howard Chiou	
34.	[Articles] Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019	IHME Pathogen Core Group	
35.	[Comment] The continuing challenge of infectious diseases	Karen H Keddy, Tesfaye Gobena	
36.	[Articles] Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021	GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators	
37.	[Comment] Unveiling the viral aetiologies of lower respiratory infections	You Li, Xin Wang	
38.	[Articles] Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial	Iman Satti, Julia L Marshall, Stephanie A Harris, Rachel Wittenberg, Rachel Tanner, Raquel Lopez Ramon, Morven Wilkie, Fernando Ramos Lopez, Michael Riste, Daniel Wright, Marco Polo Peralta Alvarez, Nicola Williams, Hazel Morrison, Elena Stylianou, Pedro Folegatti, Daniel Jenkin, Samantha Vermaak, Linnea Rask, Ingrid Cabrera Puig, Rebecca Powell Doherty, Alison Lawrie, Paul Moss, Timothy Hinks, Henry Bettinson, Helen McShane	
39.	[Comment] A new tool for accelerating tuberculosis vaccine development	Mangalakumari Jeyanathan, Zhou Xing	
40.	[Articles] An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial	Katrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, Ida Rosenkrands, Kirstine L Schmidt, Rie E Søndergaard, Suzanne Day, Abbey Evans, Leon R McFarlane, Jennifer Joypooranachandran, Fahimah Amini, Per Skallerup, Rebecca B Dohn, Charlotte G Jensen, Anja W Olsen, Peter Bang, Tom Cole, Joanna Schronce, Nana-Marie Lemm, Max P Kristiansen, Peter L Andersen, Jes Dietrich, Robin J Shattock, Frank Follmann	
41.	[Comment] Immunological responses in a Chlamydia trachomatis vaccine trial	Wilhelmina Huston	
42.	[Articles] Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial	Hong-Xing Pan, Ling-Xian Qiu, Qi Liang, Zhen Chen, Ming-Lei Zhang, Sheng Liu, Guo-Hua Zhong, Kong-Xin Zhu, Meng-Jun Liao, Jia-Lei Hu, Jia-Xue Li, Jin-Bo Xu, Yong Fan, Yue Huang, Ying-Ying Su, Shou-Jie Huang, Wei Wang, Jin-Le Han, Ji-Zong Jia, Hua Zhu, Tong Cheng, Xiang-Zhong Ye, Chang-Gui Li, Ting Wu, Feng-Cai Zhu, Jun Zhang, Ning-Shao Xia	
43.	[Comment] Is there a need for an alternative varicella vaccine?	Alemnew F Dagnew	
44.	[Articles] Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases	Florian Blanchard, Benoît Henry, Sofieya Vijayaratnam, Etienne Canouï, Alexandra Moura, Pierre Thouvenot, Hélène Bracq-Dieye, Nathalie Tessaud-Rita, Guillaume Valès, Andrée Diakité, Alexandre Leclercq, Marc Lecuit, Caroline Charlier, Listeria monocytogenes-associated Spontaneous Peritonitis Study Group	
45.	[Comment] Listeria monocytogenes: a rare, deadly cause of peritonitis	Maria Gori	
46.	[Correspondence] Plasma-based antigen persistence in the post-acute phase of COVID-19	Michael J Peluso, Zoe N Swank, Sarah A Goldberg, Scott Lu, Thomas Dalhuisen, Ella Borberg, Yasmeen Senussi, Michael A Luna, Celina Chang Song, Alexus Clark, Andhy Zamora, Megan Lew, Badri Viswanathan, Beatrice Huang, Khamal Anglin, Rebecca Hoh, Priscila Y Hsue, Matthew S Durstenfeld, Matthew A Spinelli, David V Glidden, Timothy J Henrich, J Daniel Kelly, Steven G Deeks, David R Walt, Jeffrey N Martin	
47.	[Articles] Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study	Marcela Ferrés, Constanza Martínez-Valdebenito, Carolina Henriquez, Claudia Marco, Jenniffer Angulo, Aldo Barrera, Carlos Palma, Gonzalo Barriga Pinto, Analia Cuiza, Leonila Ferreira, María Luisa Rioseco, Mario Calvo, Ricardo Fritz, Sebastián Bravo, Alejandro Bruhn, Jerónimo Graf, Alvaro Llancaqueo, Gonzalo Rivera, Carolina Cerda, Nicole Tischler, Francisca Valdivieso, Pablo Vial, Gregory Mertz, Cecilia Vial, Nicole Le Corre	
48.	[Comment] Presence of Andes orthohantavirus in human body fluids	Alemka Markotić	
49.	[Corrections] Correction to Lancet Infect Dis 2024; published online March 22. https://doi.org/10.1016/S1473-3099(24)00154-3		
50.	[Correspondence] Zoonotic tuberculosis in the 21st century	Anna S Dean, Gregorio Torres, Orr Rozov, Tereza Kasaeva	
51.	[Corrections] Correction to Lancet Infect Dis 2024; published online Feb 1. https://doi.org/10.1016/S1473-3099(23)00706-5		
52.	[Personal View] The emergence of artemisinin partial resistance in Africa: how do we respond?	Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, Melissa D Conrad, Deus S Ishengoma, Moses R Kamya, Charlotte Rasmussen, Fitsum G Tadesse, Aline Uwimana, David A Fidock	
53.	[Articles] Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial	Ynke Larivière, Trésor Zola Matuvanga, Bernard Isekah Osang'ir, Solange Milolo, Rachel Meta, Primo Kimbulu, Cynthia Robinson, Michael Katwere, Chelsea McLean, Gwen Lemey, Junior Matangila, Vivi Maketa, Patrick Mitashi, Jean-Pierre Van geertruyden, Pierre Van Damme, Hypolite Muhindo-Mavoko	
54.	[Comment] Single dose of Dengvaxia vaccine: is it a cause for alarm?	Corazon C Buerano, Kouchi Morita	
55.	[Articles] Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study	Michelle Ylade, Maria Vinna Crisostomo, Jedas Veronica Daag, Kristal An Agrupis, Anna Maureen Cuachin, Ava Kristy Sy, Deok Ryun Kim, Hyeon Seon Ahn, Ana Coello Escoto, Leah C Katzelnick, Cameron Adams, Laura White, Aravinda M de Silva, Jacqueline Deen, Anna Lena Lopez	
56.	[Comment] Post-tuberculosis lung disease: is there a light at the end of tunnel?	Jeremiah Chakaya, Razia Fatma, Mizaya Cader, Anthony D Harries	
57.	[Review] The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience	Kogieleum Naidoo, Rubeshan Perumal, Helen Cox, Barun Mathema, Marian Loveday, Nazir Ismail, Shaheed Vally Omar, Sophia B Georghiou, Amrita Daftary, Max O'Donnell, Norbert Ndjeka	
58.	[Comment] Mycobacterium tuberculosis transmission: the importance of precision	Ryan Dinkele, Palwasha Y Khan, Digby F Warner	
59.	[Correspondence] Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1	Dhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, Cameron Hurst, Charin Modchang, Sudarat Chadsuthi, Suparinthon Anupong, Kazuhiko Miyanaga, Longzhu Cui, Stefan Fernandez, Angkana T Huang, Puey Ounjai, Andrew C Singer, Naveen Kumar Devanga Ragupathi, Daisuke Sano, Takashi Furukawa, Kazunari Sei, Asada Leelahavanichkul, Talerngsak Kanjanabuch, Tanittha Chatsuwan, Paul G Higgins, Asuka Nanbo, Anthony Kicic, Richard Siow, Sam Trowsdale, Parichart Hongsing, Aisha Khatib, Kenji Shibuya, Shuichi Abe, Hitoshi Ishikawa, Pathogen Hunters Research Team	
60.	[Review] Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK	Shamez N Ladhani, Peter J White, Helen Campbell, Sema Mandal, Ray Borrow, Nick Andrews, Sunil Bhopal, John Saunders, Hamish Mohammed, Lana Drisdale-Gordon, Emma Callan, Katy Sinka, Kate Folkard, Helen Fifer, Mary E Ramsay	
61.	[Articles] Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial	Avika Dixit, Richard Bennett, Kashif Ali, Carl Griffin, Robert A Clifford, Mark Turner, Rosanne Poston, Kelly Hautzinger, Anne Yeakey, Bethany Girard, Wen Zhou, Weiping Deng, Honghong Zhou, Sabine Schnyder Ghamloush, Barbara J Kuter, Karen Slobod, Jacqueline M Miller, Frances Priddy, Rituparna Das, ROVER Study Investigators	
62.	[Comment] The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19 vaccination in children	Si-Min Li, Feng-Cai Zhu	
63.	[Articles] Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021	GBD 2021 Tuberculosis Collaborators	
64.	[Comment] Towards improving the quality and usefulness of GBD tuberculosis estimates	Richard G White, JVR Prasada Rao	
65.	[Comment] A step forward in the journey towards hookworm vaccines	Jennifer Keiser, Tiffany Bouchery	
66.	[Articles] Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial	Jeannot F Zinsou, David J Diemert, Jean Claude Dejon-Agobé, Bayodé R Adégbité, Yabo Josiane Honkpehedji, Kafui G Vodonou, Rodrigue Bikangui, Jean Ronald Edoa, Marguerite Massinga Loembe, Guangzhao Li, Maria Yazdanbakhsh, Maria Elena Bottazzi, Remko van Leeuwen, Peter G Kremsner, Peter J Hotez, Jeffrey M Bethony, Martin P Grobusch, Ayola A Adegnika	
67.	[Comment] The hidden threat of subclinical tuberculosis	Xiaolin Wei, Wenhong Zhang	
68.	[Articles] Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis	Logan Stuck, Eveline Klinkenberg, Nahid Abdelgadir Ali, Egbal Ahmed Basheir Abukaraig, Yaw Adusi-Poku, Zeleke Alebachew Wagaw, Razia Fatima, Nathan Kapata, Pascalina Kapata-Chanda, Bruce Kirenga, Llang B Maama-Maime, Sayoki G Mfinanga, Sizulu Moyo, Lindiwe Mvusi, Ndahafa Nandjebo, Hai Viet Nguyen, Hoa Binh Nguyen, Joshua Obasanya, Bashorun Adedapo Olufemi, Philip Patrobas Dashi, Thato J Raleting Letsie, Nunurai Ruswa, Elizeus Rutebemberwa, Mbazi Senkoro, Tieng Sivanna, Huot Chan Yuda, Irwin Law, Ikushi Onozaki, Edine Tiemersma, Frank Cobelens, scTB Meta Investigator Group	
69.	[Personal View] Accelerating antibiotic access and stewardship: a new model to safeguard public health	Jennifer Cohn, Marc Mendelson, Souha S Kanj, Nusrat Shafiq, Icaro Boszczowski, Ramanan Laxminarayan	
70.	[Review] Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study	Francesca Tamarozzi, Cristina Mazzi, Spinello Antinori, Marta Arsuaga, Sören L Becker, Emmanuel Bottieau, Daniel Camprubi-Ferrer, Eric Caumes, Alexandre Duvignaud, Martin P Grobusch, Stephane Jaureguiberry, Sabine Jordan, Andreas Mueller, Andreas Neumayr, Jose A Perez-Molina, Joaquin Salas-Coronas, Fernando Salvador, Lina R Tomasoni, Jaap J van Hellemond, Stephen D Vaughan, Linda J Wammes, Lorenzo Zammarchi, Dora Buonfrate, Ralph Huits, Lisette van Lieshout, Federico Gobbi	
71.	[Articles] Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial	Chijioke Bennett, Wayne Woo, Mark Bloch, King Cheung, Paul Griffin, Rahul Mohan, Sachin Deshmukh, Mark Arya, Oscar Cumming, A Munro Neville, Toni G McCallum Pardey, Joyce S Plested, Shane Cloney-Clark, Mingzhu Zhu, Raj Kalkeri, Nita Patel, Alex Marcheschi, Jennifer Swan, Gale Smith, Iksung Cho, Gregory M Glenn, Robert Walker, Raburn M Mallory, Novavax 2019nCoV-311 Study Group	
72.	[Comment] Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising booster	Ruiqi Zhang, Ivan Fan-Ngai Hung	
73.	[Review] A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study	Manu P Bilsen, Simon P Conroy, Caroline Schneeberger, Tamara N Platteel, Cees van Nieuwkoop, Lona Mody, Jeffrey M Caterino, Suzanne E Geerlings, Bela Köves, Florian Wagenlehner, Marleen Kunneman, Leo G Visser, Merel M C Lambregts, UTI Reference Standard Consensus Group	
74.	[Comment] Progress towards safer and more effective radical cure of Plasmodium vivax	Ric N Price	
75.	[Articles] Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study	Marcelo Brito, Rosilene Rufatto, José Diego Brito-Sousa, Felipe Murta, Vanderson Sampaio, Patrícia Balieiro, Djane Baía-Silva, Vanessa Castro, Brenda Alves, Aline Alencar, Stephan Duparc, Penny Grewal Daumerie, Isabelle Borghini-Fuhrer, Elodie Jambert, Cássio Peterka, Francisco Edilson Lima, Leonardo Carvalho Maia, Catherine Lucena Cruz, Bruna Maciele, Mariana Vasconcelos, Myrna Machado, Elder Augusto Figueira, Antônio Alcirley Balieiro, Dhelio Batista Pereira, Marcus Lacerda	
76.	[Corrections] Correction to Lancet Infect Dis 2024; published online Feb 8. https://doi.org/10.1016/S1473-3099(24)00062-8		
77.	[Articles] Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial	Paulo Cesar Pereira dos Santos, Nicole Louise Messina, Roberto Dias de Oliveira, Patricia Vieira da Silva, Marco Antonio Moreira Puga, Margareth Dalcolmo, Glauce dos Santos, Marcus Vinícius Guimarães de Lacerda, Bruno Araújo Jardim, Fernando Fonseca de Almeida e Val, Nigel Curtis, Jason R Andrews, Julio Croda	
78.	[Comment] Revaccination with BCG: does it work?	Helen McShane	
79.	[Articles] An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia	Bhagwat Gunale, Nicholas Farinola, Chandrashekhar D Kamat, Cyrus S Poonawalla, Sambhaji S Pisal, Rajeev M Dhere, Claire Miller, Prasad S Kulkarni	
80.	[Comment] Is a therapeutic dengue monoclonal antibody on the way?	Eng Eong Ooi, Yvonne FZ Chan	
81.	[Articles] Effectiveness of pyriproxyfen-pyrethroid and chlorfenapyr-pyrethroid long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs for malaria control in the third year post-distribution: a secondary analysis of a cluster-randomised controlled trial in Benin	Manfred Accrombessi, Jackie Cook, Edouard Dangbenon, Arthur Sovi, Boulais Yovogan, Landry Assongba, Constantin J Adoha, Bruno Akinro, Cyriaque Affoukou, Germain Gil Padonou, Immo Kleinschmidt, Louisa A Messenger, Mark Rowland, Corine Ngufor, Martin C Akogbeto, Natacha Protopopoff	
82.	[Comment] Is the next generation of mosquito nets surviving expectations?	Sarah Moore, Stephan Karl	
83.	[Grand Round] Transjugular intrahepatic portosystemic shunt followed by splenectomy for complicated hepatosplenic schistosomiasis: a case report and review of the literature	Francesca Tamarozzi, Tamara Ursini, Giacomo Stroffolini, Geraldo Badona Monteiro, Dora Buonfrate, Veronica Andrea Fittipaldo, Simone Conci, Clizia Gasparini, Giancarlo Mansueto, Alfredo Guglielmi, Federico Gobbi	
84.	[Personal View] Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions	Lao-Tzu Allan-Blitz, Helen Fifer, Jeffrey D Klausner	
85.	[Articles] Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials	Xiaojiao Li, Yusi Liu, Meng Wang, Lei Gao, Jingrui Liu, Hong Zhang, Min Wu, Hong Chen, Jinfeng Lou, Jing Wang, Jing Chen, Guozhu Geng, Zhenkun Ma, Yanhua Ding	
86.	[Comment] A novel dual targeted antibacterial agent for Helicobacter pylori	Jinnan Chen, Hong Lu	
87.	[Review] Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM	Christina C Chang, Thomas S Harrison, Tihana A Bicanic, Methee Chayakulkeeree, Tania C Sorrell, Adilia Warris, Ferry Hagen, Andrej Spec, Rita Oladele, Nelesh P Govender, Sharon C Chen, Christopher H Mody, Andreas H Groll, Yee-Chun Chen, Michail S Lionakis, Alexandre Alanio, Elizabeth Castañeda, Jairo Lizarazo, José E Vidal, Takahiro Takazono, Martin Hoenigl, Jan-Willem Alffenaar, Jean-Pierre Gangneux, Rajeev Soman, Li-Ping Zhu, Alexandro Bonifaz, Joseph N Jarvis, Jeremy N Day, Nikolai Klimko, Jon Salmanton-García, Grégory Jouvion, David B Meya, David Lawrence, Sebastian Rahn, Felix Bongomin, Brendan J McMullan, Rosanne Sprute, Tinashe K Nyazika, Justin Beardsley, Fabianne Carlesse, Christopher H Heath, Olusola O Ayanlowo, Olga M Mashedi, Flavio Queiroz-Telles Filho, Mina C Hosseinipour, Atul K Patel, Elvis Temfack, Nina Singh, Oliver A Cornely, David R Boulware, Olivier Lortholary, Peter G Pappas, John R Perfect	
88.	[Personal View] Persistent SARS-CoV-2 infection: significance and implications	Heather M Machkovech, Anne M Hahn, Jacqueline Garonzik Wang, Nathan D Grubaugh, Peter J Halfmann, Marc C Johnson, Jacob E Lemieux, David H O'Connor, Anne Piantadosi, Wanting Wei, Thomas C Friedrich	
89.	[Articles] Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo	Rebecca M Coulborn, Mathieu Bastard, Nicolas Peyraud, Etienne Gignoux, Francisco Luquero, Bérengère Guai, Stephane Hans Bateyi Mustafa, Elisabeth Mukamba Musenga, Steve Ahuka-Mundeke	
90.	[Comment] Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival	William A Fischer, David A Wohl	
91.	[Articles] Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study	Reena H Doshi, Patrick K Mukadi, Rebecca M Casey, Gabriel M Kizito, Hongjiang Gao, Beatrice Nguete U, Janeen Laven, Lilliane Sabi, Didine K Kaba, Jean-Jacques Muyembe-Tamfum, Terri B Hyde, Steve Ahuka-Mundeke, J Erin Staples	
92.	[Comment] Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines	Aitana Juan-Giner, George Warimwe	
93.	[Review] Emergence of Oropouche fever in Latin America: a narrative review	Konrad M Wesselmann, Ignacio Postigo-Hidalgo, Laura Pezzi, Edmilson F de Oliveira-Filho, Carlo Fischer, Xavier de Lamballerie, Jan Felix Drexler	
94.	[Review] Global incidence and mortality of severe fungal disease	David W Denning	
95.	[Personal View] Nipah virus disease: what can we do to improve patient care?	Md Zakiul Hassan, Tahmina Shirin, Syed M Satter, Mohammed Z Rahman, Josephine Bourner, Ashleigh Cheyne, Els Torreele, Peter Horby, Piero Olliaro	
96.	[Review] Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review	Kikanwa Anyiwe, Aysegul Erman, Marian Hassan, Jordan J Feld, Eleanor Pullenayegum, William W L Wong, Beate Sander	
97.	[Personal View] The role of asymptomatic infections in influenza transmission: what do we really know	Martha P Montgomery, Sinead E Morris, Melissa A Rolfes, Wanitchaya Kittikraisak, Aaron M Samuels, Matthew Biggerstaff, William W Davis, Carrie Reed, Sonja J Olsen	
98.	[Personal View] The global burden of fracture-related infection: can we do better?	Willem-Jan Metsemakers, T Fintan Moriarty, Mario Morgenstern, Leonard Marais, Jolien Onsea, Robert V O'Toole, Melissa Depypere, William T Obremskey, Michael H J Verhofstad, Martin McNally, Saam Morshed, Marjan Wouthuyzen-Bakker, Charalampos Zalavras	

更新于 57 分钟前

近期历史最近 100 条记录

2024-05-18	[Articles] Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial	Muge Cevik, Lindsay C Thompson, Caryn Upton, Valéria Cavalcanti Rolla, Mookho Malahleha, Blandina Mmbaga, Nosipho Ngubane, Zamzurina Abu Bakar, Mohammed Rassool, Ebrahim Variava, Rodney Dawson, Suzanne Staples, Umesh Lalloo, Cheryl Louw, Francesca Conradi	
2024-05-18	[Comment] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis	Guofang Deng, Liang Fu	
2024-05-16	[Articles] Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study	Ida Rask Moustsen-Helms, Peter Bager, Tine Graakjær Larsen, Frederik Trier Møller, Lasse Skafte Vestergaard, Morten Rasmussen, Christian Holm Hansen, SSI-DMC Study Group	
2024-05-16	[Comment] Immune evasiveness of SARS-CoV-2 variants and vaccine selection	Malin Inghammar, Fredrik Kahn	
2024-05-09	[Articles] Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study	Jelte Elsinga, Temmy Sunyoto, Letizia di Stefano, Pier Francesco Giorgetti, Htet Aung Kyi, Chiara Burzio, Ximena Campos Moreno, Chiedozie K Ojide, Nnennaya Ajayi, Richard Ewah, Emeka O Ogah, Chioma Dan-Nwafor, Anthony Ahumibe, Chinwe Lucia Ochu, Adebola O	
2024-05-09	[Comment] Rapid diagnostic tests for Lassa fever: what do we aim for?	Mirjam Groger, Michael Ramharter	
2024-05-09	[Personal View] Urgent considerations for booster vaccination strategies against Ebola virus disease	Wim Adriaensen, Selien Oostvogels, Yves Levy, Bailah Leigh, Hugo Kavunga-Membo, Deborah Watson-Jones	
2024-05-09	[Personal View] Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity	Mathew Mercuri, Kristy Hackett, Ruanne V Barnabas, Claudia I Emerson	
2024-05-09	[Comment] Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities	Dvora Joseph Davey, Alex de Voux, Lerato Hlatshwayo, Aurelie Nelson, Lisa Frigati, Kalisha Bheemraj, Nafisa Wara, Rufaro Mvududu, Landon Myer	
2024-05-07	[Correspondence] Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam	Paul C Adamson, Vu N Hieu, Pham H Nhung, DM Whiley, TM Chau	
2024-05-07	[Articles] Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised cont	Michal Juraska, Angela M Early, Li Li, Stephen F Schaffner, Marc Lievens, Akanksha Khorgade, Brian Simpkins, Nima S Hejazi, David Benkeser, Qi Wang, Laina D Mercer, Samuel Adjei, Tsiri Agbenyega, Scott Anderson, Daniel Ansong, Dennis K Bii, Patrick B Y Bu	
2024-05-07	[Comment] Asymptomatic parasitemia and RTS,S vaccine efficacy	Nobuko Arisue, Nirianne Marie Q Palacpac	
2024-05-07	[Corrections] Correction to Lancet Infect Dis 2024; published online April 3. https://doi.org/10.1016/S1473-3099(24)00142-7		
2024-05-04	[Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study	Huwen Wang, Yuchen Wei, Chi Tim Hung, Guozhang Lin, Xiaoting Jiang, Conglu Li, Katherine Min Jia, Carrie Ho Kwan Yam, Tsz Yu Chow, Janice Ying-en Ho, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Eng Kiong Yeoh,	
2024-05-04	[Comment] Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection	Vicente Soriano, Víctor Moreno-Torres	
2024-05-02	[Correspondence] Shifting transmission patterns of human mpox in South Kivu, DR Congo	Patrick DMC Katoto, Winters Muttamba, Esto Bahizire, Espoir Bwenge Malembaka, Henry Kyobe Bosa, Dieudonné Mwamba Kazadi, Gaston Lubambo, Freddy Belesi Siangoli, Barnabas Bakamutumaho, Misaki Wayengera, Don Jethro Mavungu Landu, Daniel Mukadi-Bamuleka, Pla	
2024-05-01	[Articles] Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study	Sonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, Jacobo Pardo-Seco, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Suárez-Gaiche, Rolf Kramer, Jing Jin, Leticia Platero-Alonso, Rosa-María Alvárez-Gil, Olga-María Ces-Ozores, Victoria	
2024-05-01	[Correspondence] Reporting of deaths during cholera outbreaks: case fatality ratio and community deaths	Flavio Finger, Kristen Heitzinger, David Berendes, Iza Ciglenecki, Morgane Dominguez, Kate Alberti, Emmanuel Baron, Philippe Barboza	
2024-05-01	[Comment] Early life respiratory syncytial virus disease—a preventable burden	Cheryl Cohen, Heather J Zar	
2024-04-30	[Corrections] Correction to Lancet Infect Dis 2019; 19: 1380		
2024-04-26	[Articles] Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study	Morgan K Walker, Guoqing Diao, Sarah Warner, Ahmed Babiker, Maniraj Neupane, Jeffrey R Strich, Christina Yek, Sameer S Kadri, National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI)	
2024-04-26	[Articles] Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial	Kirsten E Lyke, Joel V Chua, Michael Koren, Heather Friberg, Gregory D Gromowski, Rekha R Rapaka, Adam T Waickman, Sudhaunshu Joshi, Kathleen Strauss, Michael K McCracken, Hernando Gutierrez-Barbosa, Biraj Shrestha, Christopher Culbertson, Paula Bernal, R	
2024-04-26	[Comment] Lessons for dengue vaccines from a human challenge study	Eng Eong Ooi, Shirin Kalimuddin	
2024-04-26	[Comment] Carbapenem use in US hospitals: guidance and stewardship	Erika J Ernst	
2024-04-25	[Articles] Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)	Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupaka	
2024-04-25	[Comment] Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape	Leo G Visser	
2024-04-24	[Comment] Reducing risks from respiratory pathogens at the 2024 Hajj	Ziad A Memish, Majid M Alshamrani, Rana F Kattan, Esam I Azhar, Fayssal M Farahat, Ali M Albarrak, Alimuddin Zumla	
2024-04-23	[Articles] The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China	Wenting Zuo, Di He, Chaoyang Liang, Shiyu Du, Zhan Hua, Qiangqiang Nie, Xiaofeng Zhou, Meng Yang, Haidong Tan, Jiuyang Xu, Yanbing Yu, Yuliang Zhan, Ying Zhang, Xiaoying Gu, Weijie Zhu, Hui Zhang, Hongyan Li, Weiliang Sun, Mingzhi Sun, Xiaolei Liu, Liguo	
2024-04-23	[Comment] Long COVID and SARS-CoV-2 persistence: new answers, more questions	Danilo Buonsenso, Kelan G Tantisira	
2024-04-23	[Newsdesk] Pertussis outbreak in Czech Republic	Ed Holt	
2024-04-23	[Media Watch] Family and sexual behaviour in South Africa	Hollie Sherwood-Martin	
2024-04-23	[Media Watch] Community perspectives on abortion in eastern South Africa	Sylvia Warren	
2024-04-20	[Historical Review] Social histories of public health misinformation and infodemics: case studies of four pandemics	Sabrina L Jin, Jessica Kolis, Jessica Parker, Dylan A Proctor, Dimitri Prybylski, Claire Wardle, Neetu Abad, Kathryn A Brookmeyer, Christopher Voegeli, Howard Chiou	
2024-04-17	[Articles] Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019	IHME Pathogen Core Group	
2024-04-17	[Comment] The continuing challenge of infectious diseases	Karen H Keddy, Tesfaye Gobena	
2024-04-16	[Articles] Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021	GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators	
2024-04-16	[Comment] Unveiling the viral aetiologies of lower respiratory infections	You Li, Xin Wang	
2024-04-13	[Articles] Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial	Iman Satti, Julia L Marshall, Stephanie A Harris, Rachel Wittenberg, Rachel Tanner, Raquel Lopez Ramon, Morven Wilkie, Fernando Ramos Lopez, Michael Riste, Daniel Wright, Marco Polo Peralta Alvarez, Nicola Williams, Hazel Morrison, Elena Stylianou, Pedro	
2024-04-13	[Comment] A new tool for accelerating tuberculosis vaccine development	Mangalakumari Jeyanathan, Zhou Xing	
2024-04-12	[Articles] An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial	Katrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, Ida Rosenkrands, Kirstine L Schmidt, Rie E Søndergaard, Suzanne Day, Abbey Evans, Leon R McFarlane, Jennifer Joypooranachandran, Fahimah Amini, Per Skallerup, Rebecca B Dohn, Charlotte G Jensen, Anja	
2024-04-12	[Comment] Immunological responses in a Chlamydia trachomatis vaccine trial	Wilhelmina Huston	
2024-04-11	[Articles] Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial	Hong-Xing Pan, Ling-Xian Qiu, Qi Liang, Zhen Chen, Ming-Lei Zhang, Sheng Liu, Guo-Hua Zhong, Kong-Xin Zhu, Meng-Jun Liao, Jia-Lei Hu, Jia-Xue Li, Jin-Bo Xu, Yong Fan, Yue Huang, Ying-Ying Su, Shou-Jie Huang, Wei Wang, Jin-Le Han, Ji-Zong Jia, Hua Zhu, Ton	
2024-04-11	[Comment] Is there a need for an alternative varicella vaccine?	Alemnew F Dagnew	
2024-04-10	[Articles] Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases	Florian Blanchard, Benoît Henry, Sofieya Vijayaratnam, Etienne Canouï, Alexandra Moura, Pierre Thouvenot, Hélène Bracq-Dieye, Nathalie Tessaud-Rita, Guillaume Valès, Andrée Diakité, Alexandre Leclercq, Marc Lecuit, Caroline Charlier, Listeria monocytogene	
2024-04-10	[Comment] Listeria monocytogenes: a rare, deadly cause of peritonitis	Maria Gori	
2024-04-09	[Correspondence] Plasma-based antigen persistence in the post-acute phase of COVID-19	Michael J Peluso, Zoe N Swank, Sarah A Goldberg, Scott Lu, Thomas Dalhuisen, Ella Borberg, Yasmeen Senussi, Michael A Luna, Celina Chang Song, Alexus Clark, Andhy Zamora, Megan Lew, Badri Viswanathan, Beatrice Huang, Khamal Anglin, Rebecca Hoh, Priscila Y	
2024-04-09	[Media Watch] A summer cold	Marco De Ambrogi	
2024-04-04	[Comment] Presence of Andes orthohantavirus in human body fluids	Alemka Markotić	
2024-04-04	[Articles] Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study	Marcela Ferrés, Constanza Martínez-Valdebenito, Carolina Henriquez, Claudia Marco, Jenniffer Angulo, Aldo Barrera, Carlos Palma, Gonzalo Barriga Pinto, Analia Cuiza, Leonila Ferreira, María Luisa Rioseco, Mario Calvo, Ricardo Fritz, Sebastián Bravo, Aleja	
2024-03-30	[Correspondence] Zoonotic tuberculosis in the 21st century	Anna S Dean, Gregorio Torres, Orr Rozov, Tereza Kasaeva	
2024-03-30	[Corrections] Correction to Lancet Infect Dis 2024; published online March 22. https://doi.org/10.1016/S1473-3099(24)00154-3		
2024-03-28	[Corrections] Correction to Lancet Infect Dis 2024; published online Feb 1. https://doi.org/10.1016/S1473-3099(23)00706-5		
2024-03-27	[Personal View] The emergence of artemisinin partial resistance in Africa: how do we respond?	Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, Melissa D Conrad, Deus S Ishengoma, Moses R Kamya, Charlotte Rasmussen, Fitsum G Tadesse, Aline Uwimana, David A Fidock	
2024-03-27	[Articles] Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, ran	Ynke Larivière, Trésor Zola Matuvanga, Bernard Isekah Osang'ir, Solange Milolo, Rachel Meta, Primo Kimbulu, Cynthia Robinson, Michael Katwere, Chelsea McLean, Gwen Lemey, Junior Matangila, Vivi Maketa, Patrick Mitashi, Jean-Pierre Van geertruyden, Pierre	